Item 8.01 Other Events.

In connection with Bright Health Group, Inc.'s ("we" or the "Company") initial public offering (the "IPO"), our directors, executive officers and significant equityholders entered into lock-up agreements with the underwriters of the IPO that, subject to certain exceptions, restrict such holders' ability to sell, dispose of or hedge any shares of our common stock or securities convertible into or exchangeable for shares of common stock during the period from June 23, 2021 continuing through the date 180 days thereafter (the "Lock-Up Period"). All remaining holders of common stock or securities convertible into or exchangeable for shares of common stock outstanding immediately prior to the consummation of the IPO are subject to market standoff agreements with the Company that restrict certain transfers of such securities for up to 180 days after June 23, 2021. The lock-up agreements with the underwriters provide that if such 180-day period ends during or within the nine trading days of the start of a regularly scheduled trading black-out period under the Company's insider trading policy, the above referenced expiration date will instead be the tenth trading day immediately preceding the commencement of such trading black-out period.

The Lock-Up Period is scheduled to end on December 20, 2021, which falls within the Company's quarterly black-out period that commences on December 15, 2021. Therefore, in accordance with the lock-up agreements with the underwriters, the Lock-Up Period will end on December 1, 2021, and shares subject to the Lock-Up Period will be eligible to begin trading on December 2, 2021, subject to volume and other limitations and restrictions. The Company will also release the holders subject to the market standoff agreements when such Lock-Up Period ends.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.
       Exhibit
         No.                                              Description
                             The cover page from the Current Report on Form 8-K formatted in
         104                 Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses